Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Recent research has raised hopes for impressively accurate screening for cancer with molecular biomarkers. In this Essay, John A. Baron argues that more sensitive screening tests might be clinically valuable — but that they will present unique issues in implementation and interpretation.
As the eightieth anniversary of the first description of Fanconi anaemia approaches, Stephan Lobitz and Eunike Velleuer look back on his career as a paediatrician and his contribution to cancer research.